In the last year, many Moderna, Inc. ( NASDAQ:MRNA ) insiders sold a substantial stake in the company which may have...
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.